Morgan D B, Davidson C
Br Med J. 1980 Mar 29;280(6218):905-8. doi: 10.1136/bmj.280.6218.905.
Published data have been used to define the characteristics of the fall in serum potassium concentration after taking diuretics and the efficacy of the various treatments given to prevent or correct it. The average fall is less after the usual doses of frusemide (about 0.3 mmol/l) than after the usual doses of thiazides (about 0.6 mmol/l) and is little influenced by the dose or duration of treatment. The fall with a given drug is the same in heart failure and hypertension, but the initial serum potassium concentration is higher in heart failure, so that the final value is lower in hypertension. In standard doses potassium supplements are less effective than potassium-retaining diuretics in correcting the hypokalaemia. The relation between the average serum potassium value and the frequency of low values (hypokalaemia) is such that very low values after taking diuretics are unusual in patients with hypertension or heart failure. Hypokalaemia would almost disappear as an important complication of diuretic treatment if it was defined as a value less than 3.0 mmol/l rather than as a value less than 3.5 mmol/l.
已发表的数据被用于定义服用利尿剂后血清钾浓度下降的特征,以及用于预防或纠正该情况的各种治疗方法的疗效。通常剂量的速尿(约0.3 mmol/l)导致的平均下降幅度小于通常剂量的噻嗪类药物(约0.6 mmol/l),且受治疗剂量或疗程的影响较小。使用特定药物时,心力衰竭和高血压患者的血钾下降情况相同,但心力衰竭患者的初始血清钾浓度较高,因此高血压患者的最终血钾值较低。标准剂量的钾补充剂在纠正低钾血症方面不如保钾利尿剂有效。平均血清钾值与低钾值(低钾血症)发生频率之间的关系表明,服用利尿剂后出现极低血钾值在高血压或心力衰竭患者中并不常见。如果将低钾血症定义为血钾值低于3.0 mmol/l而非低于3.5 mmol/l,那么低钾血症作为利尿剂治疗的一个重要并发症几乎会消失。